Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 898 publications.

Hudgens S, Regnault A, McLeod LD, Martin M, Eremenco S. Clinical outcomes assessment in a multi-cultural context: measurement challenges and recommendations. Presented at the International Society for Quality of Life Research Conference; December 17, 2015.

Strand V, Ahadieh S, French J, Geier J, Krishnaswami S, Menon S, Checchio T, Tensfeldt TG, Hoffman E, Riese R, Boy M, Gomez-Reino JJ. Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials. Arthritis Res Ther. 2015 Dec 15;17(1):362. doi: 10.1186/s13075-015-0880-2

Lee S, Wolf D, Feagan B, Lichtenstein G, Andrews E, Stidham R, Aberra M, Aguilar H, Kayhan C, Kosutic G, Sen D, Golembesky A, Hasan I, Spearman M, Loftus E. An observational study of certolizumab pegol in Crohn's disease - an adverse events of interest analysis with 5869 patient-years at risk. Poster presented at the Crohn's and Colitis Foundation of America's Clinical and Research Conference; December 10, 2015. Orlando, FL.

Hess LM, Rajan N, Winfree K, Davey P, Ball M, Knox H, Graham C. Cost analyses in the US and Japan: a cross-country comparative analysis applied to the PRONOUNCE trial in non-squamous non-small cell lung cancer. Adv Ther. 2015 Dec 9;32(12):1248-62. doi: 10.1007/s12325-015-0270-9

Montserrat-Capdevila J, Godoy P, Marsal JR, Barbe F, Galvan L. Risk of exacerbation in chronic obstructive pulmonary disease: a primary care retrospective cohort study. BMC Fam Pract. 2015 Dec 8;16:173. doi: 10.1186/s12875-015-0387-6

Liede A, Fairchild A, Friedman S, Amelio J, Hallett DC, Mansfield CA, Metcalfe KA. Risk-reducing surgery and cancer-related distress among female BRCA1 and BRCA2 mutation carriers. Poster presented at the 2015 San Antonio Breast Cancer Symposium; December 8, 2015. San Antonio, TX.

Ramamohan V, Abbott JT, Yih Y. Effect of uncertainty in calibration on the correlation structure of the rheumatoid factor immunoassay calibration function. Presented at the 2015 Winter Simulation Conference; December 6, 2015. Huntington Beach, CA.

Darden CM, Price MA, Kaye JA, Sherif BN, Marion S, Tzivelekis S, Garcia J, Chandler D. Same-day administration of pegfilgrastim following myelosuppressive chemotherapy: practices and rationale. Blood. 2015 Dec 3;126(23):5585. doi: 10.1182/blood.V126.23.5585.5585

Broekhuizen H, Groothuis-Oudshoorn CG, Hauber AB, Jansen JP, IJzerman MJ. Estimating the value of medical treatments to patients using probabilistic multi criteria decision analysis. BMC Med Inform Decis Mak. 2015 Dec 2;15(1):102. doi: 10.1186/s12911-015-0225-8

Hauber B. Patient preference studies. Presented at the University of Washington, Graduate Program in Pharmaceutical Outcomes Research and Policy; December 2, 2015. Seattle, WA.

Hall AJ, Naleway AL, Esterberg EJ, Moua K, Donald J, DeBess EE, Biggs C, Schmidt M. Incidence of medically-attended acute gastroenteritis and norovirus infection across the age spectrum. Poster presented at the ID Week 2015 Conference; October 2015. San Diego, CA. [abstract] Open Forum Infect Dis. 2015 Dec; 2(1 Suppl). doi: 10.1093/ofid/ofv131.181

Hundt Golden A. Cultural groups and community organizations and their effects on women's capacity building, social empowerment, and combating feminicide in Ciudad Juárez. Presented at the University of Wisconsin-Madison. SoHE Proseminar; December 2015. Madison, WI.

Hundt Golden A. La Red Mesa de Mujeres de Ciudad Juárez: feasibility study concerning improving the safety of women through transportation initiatives and interventions. Presented at the University of Wisconsin-Madison. SoHE Evaluation Research Seminar; December 2015. Madison, WI.

Hundt Golden A. Feeding Wisconsin & AmeriCorps feasibility study. Presented at the University of Wisconsin-Madison. SoHE; December 2015. Madison, WI.

Fernandez MM, Wang J, Ye X, Kwong WJ, Sherif B, Hogue S, Sherrill B. Systematic review and network meta-analysis of the relative efficacy and safety of edoxaban versus other nonvitamin K antagonist oral anticoagulants among patients with nonvalvular atrial fibrillation and CHADS2 score slanted greater than or equal to 2. SAGE Open Med. 2015 Dec. doi: 10.1177/2050312115613350

Huisman MV, Rothman KJ, Paquette M, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Marin C, Ma CS, Zint K, Elsaesser A, Baretls DB, Lip GY. Antithrombotic treatment patterns in 10,871 patients with newly diagnosed non-valvular atrial fibrillation: the GLORIA-AF Registry Program, Phase II. Am J Med. 2015 Dec;128(12):1303-1313. doi: 10.1016/j.amjmed.2015.07.013

Davis KL, Meyers J, Zhao Z, McCollam PL, Murakami M. High-risk atherosclerotic cardiovascular disease in a real-world employed Japanese population: prevalence, cardiovascular event rates, and costs. J Atheroscler Thromb. 2015 Dec 1;22(12):1287-304. doi: 10.5551/jat.28852

Winnette R, Zárate V, Machnicki G, Demuro-Mercon C, Gawlicki M, Gnanasakthy A. Patient-reported outcomes in Latin America: implementation in research and role in emerging HTA systems. Value in Health Regional Issues. 2015 Dec;8:49-55. doi: 10.1016/j.vhri.2015.03.008

Ajmera MR, Raval AD, Zhou S, Wei W, Bhattacharya R, Pan C, Sambamoorthi U. A real-world observational study of time to treatment intensification among elderly patients with inadequately controlled type 2 diabetes mellitus. J Manag Care Spec Pharm. 2015 Dec;21(12):1184-93.

Aronsson M, Husberg M, Kalkan A, Eckard N, Alwin J. Differences between hypothetical and experience-based value sets for EQ-5D used in Sweden: implications for decision makers. Scand J Public Health. 2015 Dec;43(8):848-54. doi: 10.1177/1403494815596910

Arana A, Johannes CB, McQuay LJ, Varas-Lorenzo C, Fife D, Rothman KJ. Risk of out-of-hospital sudden cardiac death in users of domperidone, proton pump inhibitors, or metoclopramide: a population-based nested case-control study. Drug Saf. 2015 Dec;38(12):1187-99. doi: 10.1007/s40264-015-0338-0.

Li L, Kulldorff M, Russek-Cohen E, Kawai AT, Hua W. Quantifying the impact of time-varying baseline risk adjustment in the self-controlled risk interval design. Pharmacoepidemiol Drug Saf. 2015 Dec;24(12):1304-12. doi: 10.1002/pds.3885

Schwab PE, MacLean E, Chioda M, Moll K, Pasquale M, Mardekian J, Futch T. NSCLC observations combining medical charts and administrative claims data. Poster presented at the 2015 AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; November 5, 2015. Boston, MA. [abstract] Mol Tar Can Ther. 2015 Dec 1; 14(12 S2).

Belozeroff V, Chertow GM, Graham CN, Dehmel D, Parfrey PS, Briggs AH. Economic evaluation of cinacalcet in the United States: the EVOLVE trial. Value Health. 2015 Dec;18(8):1079-87. doi: 10.1016/j.jval.2015.08.007

Kumar S, Robins RH, Buck PM, Hickling TP, Thangakani AM, Li L, Singh SK, Gromiha MM. Biopharmaceutical informatics: applications of computation in biologic drug development. In: Kumar S, Singh SK, editors. Developability of biotherapeutics: computational approaches. 1st ed. Boca Raton: FL. CRC Press; 2015. p.3-34.

Kauf TL, Yang JC, Kimball AB, Sundaram M, Bao Y, Okun M, Mulani P, Hauber AB, Johnson FR. Psoriasis patients' willingness to accept side-effect risks for improved treatment efficacy. J Dermatolog Trea. 2015 Dec;26(6):507-13. doi: 10.3109/09546634.2015.1034071

Brodovicz KG, Chen Y, Liu Z, Ritchey ME, Liao J, Engel SS. Characterization of sitagliptin use in patients with type 2 diabetes and chronic kidney disease by cross-sectional analysis of a medical insurance claims database. Diabetes Ther. 2015 Dec;6(4):627-34. doi: 10.1007/s13300-015-0133-z

Novick D, Montgomery WS, Aguado J, Peng X, Brugnoli R, Haro JM. Which somatic symptoms are associated with an unfavorable course in Chinese patients with major depressive disorder? Asia Pac Psychiatry. 2015 Dec;7(4):427-35. doi: 10.1111/appy.12189

Lairson DR, Parikh RC, Cormier JN, Wenyaw C, Du XL. Cost-effectiveness of chemotherapy for breast cancer and age effect in older women. Value Health. 2015 Dec;18(8):1070-8. doi: 10.1016/j.jval.2015.08.008

Du XL, Parikh RC, Lairson DR. Racial and geographic disparities in the patterns of care and costs at the end of life for patients with lung cancer in 2007–2010 after the 2006 introduction of bevacizumab. Lung Cancer. 2015 Dec;90(3):442-50.

Jackson T. Outsourcing: building a partnership for project success. Presented at the Barnett International (Cambridge Health Institute) Live Seminar; December 2015. Philadelphia, PA.

Hahn KA, Hatch EE, Rothman KJ, Mikkelsen EM, Brogly SB, Sorensen HT, Riis AH, Wise LA. History of oral contraceptive use and risk of spontaneous abortion. Ann Epidemiol. 2015 Dec;25(12):936-941 e. doi: 10.1016/j.annepidem.2015.09.001

Zerbini C, Radominski S, Cardiel MH, Castaneda O, Romero F, Citera G, Neira O, Ponce de Leon D, Hoffman E, Rojo R. Efficacy and safety of tofacitinib monotherapy versus combination therapy in a Latin American subpopulation of patients with rheumatoid arthritis: a pooled Phase 3 analysis. Poster presented at the 2015 ACR/ARMP Annual Meeting; November 10, 2015. San Francisco, CA. [abstract] Arthritis Rheumatol. 2015 Dec; 67(suppl 10).

Lupo PJ, Danysh HE, Symanski E, Langlois PH, Cai Y, Swartz MD. Neighborhood-based socioeconomic position and risk of oral clefts among offspring. Am J Public Health. 2015 Dec;105(12):2518-25. doi: 10.2105/AJPH.2015.302804

Aranda E, Aparicio J, Alonso V, Garcia-Albeniz X, Garcia-Alfonso P, Salazar R, Valladares M, Vera R, Vieitez JM, Garcia-Carbonero R. SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015. Clin Transl Oncol. 2015 Dec;17(12):972-81. doi: 10.1007/s12094-015-1434-4

Lacour JP, Giordano-Labadie F, Martin L, Staumont-Salle D, Tian H, McBride D, Radder C, Thénié C, Pinton P, Balp MM, Bérard F. Study of the economic and human impact of spontaneous chronic urticaria: ASSURE-CSU study. Presented at the Les Journées Dermatologiques de Paris 2015; December 2015. Paris, France.

Turner AJ, Fichera E, Sutton M. The effects of in-utero exposure to influenza on the child mental health and longevity of a British cohort. Presented at the 2015 CLOSER Conference; November 30, 2015. London, United Kingdom.

Mohamed AF, Gonzalez JM, Fairchild A. Patient benefit-risk tradeoffs for radioactive iodine-refractory differentiated thyroid cancer treatments. J Thyroid Res. 2015 Nov 30;2015(438235). doi: 10.1155/2015/438235

Basarir H, Brennan A, Jacques R, Pollard DJ, Stevens K, Freeman J. The cost-effectiveness of the Kids in Control OF Food (KICk-OFF) structured education programme for adolescents with type 1 diabetes. Presented at the 2015 British Society for Paediatric Endocrinology and Diabetes; November 27, 2015. Sheffield, United Kingdom.

Rodes-Cabau J, Horlick E, Ibrahim R, Cheema AN, Labinaz M, Nadeem N, Osten M, Cote M, Marsal JR, Rivest D, Marrero A, Houde C. Effect of clopidogrel and aspirin vs aspirin alone on migraine headaches after transcatheter atrial septal defect closure: the CANOA randomized clinical trial. JAMA. 2015 Nov 24;314(20):2147-54. doi: 10.1001/jama.2015.13919

McMichael AJ, Rolison JJ, Boeri M, O'Kane J, O'Neill T, Kee F. Challenges for the stratified medicine paradigm in treating chronic mental illness. Time to pay attention to what counts. Poster presented at the 6th Annual UKCRC Public Health Research Centre of Excellence Conference; November 19, 2015. Edinburgh, United Kingdom.

Kohler RE, Goyal RK, Lich KH, Domino ME, Wheeler SB. Association between medical home enrollment and health care utilization and costs among breast cancer patients in a state Medicaid program. Cancer. 2015 Nov 15;121(22):3975-81. doi: 10.1002/cncr.29596

Merdan S, Tomlins SA, Barnett CL, Morgan TM, Montie JE, Wei JT, Denton BT. Assessment of long-term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy. Cancer. 2015 Nov 15;121(22):4071-9. doi: 10.1002/cncr.29611

Lebwohl M, Gottlieb A, Elewski B, Rich P, Jazayeri S, Reich K, Nyirady J, Zhao Y, Tran MH, McLeod L, Mordin M, Nelson L, Strober B. Secukinumab impact on patient-reported psoriasis experiences: analysis of the psoriasis symptom diary from the ERASURE and FIXTURE trials. Poster presented at the SDPA 13th Annual Fall Dermatology Conference; November 12, 2015. Orlando, FL. Previously presented at the 73rd Annual Meeting of the American Academy of Dermatology.

Marsh K, Moller J, Basarir H, Detzel P. The economic impact of SHAPE formula for the children of overweight and obese mothers. Poster presented at the 2015 ISPOR 18th Annual European Congress; November 11, 2015. Milan, Italy.

Kivitz AJ, Haraoui B, Kaine J, Castellano V, Bananis E, Connell CA, Hoffman E, Takiya L. A safety analysis of tofacitinib 5mg twice daily administered as monotherapy or in combination with background conventional synthetic DMARDs in a phase 3 rheumatoid arthritis population. Presented at the 2015 ACR/ARHP Annual Meeting; November 9, 2015. San Francisco, CA.

Nash Smyth E, La E, Talbird S, Li L, Kaye JA, Lin AB, Bowman L. Treatment patterns and health care resource use (HCRU) associated with repeatedly treated metastatic squamous cell carcinoma of the head and neck (SCCHN) in the United Kingdom (UK). Poster presented at the 2015 ISPOR 18th Annual European Congress; November 9, 2015. Milan, Italy.

Milien M. Occupation-based intervention in long-term care: evidence-based practice findings. Presented at the Texas Occupational Therapy Association; November 7, 2015.

Doward L. PROs, payers and the 5th hurdle. Presented at the 2015 ISPOR 18th Annual European Congress; November 7, 2015. Milan, Italy.

Singh M, Rebordosa C, Bernholz J, Sharma N. Epidemiology and genetics of cystic fibrosis in Asia: in preparation for the next-generation treatments. Respirology. 2015 Nov 6;20(8):1172-81. doi: 10.1111/resp.12656